First-Trimester Ultrasound Assessment of Velamentous Cord Insertion (1T-VCI)
Prospective Study of First-Trimester Ultrasound Direct Visualisation of Velamentous Cord Insertion
The goal of this observational study is to learn whether a short ultrasound assessment during the routine first-trimester pregnancy scan can identify velamentous cord insertion, an abnormal location where the umbilical cord joins the placenta. The study will include pregnant participants aged 18 years or older with a singleton pregnancy who attend first-trimester combined screening between 11+0 and 13+6 weeks of pregnancy.
The main questions it aims to answer are:
- How often can the placental cord-insertion site be successfully classified within a 3-minute assessment?
- How accurately does first-trimester ultrasound identify velamentous cord insertion compared with examination of the placenta after delivery?
Participants will:
- Attend their usual first-trimester ultrasound examination.
- Have an additional transabdominal ultrasound assessment of the placental cord-insertion site after the routine scan, taking no more than 3 minutes.
- Allow the study team to review relevant pregnancy and birth records.
- If they deliver at the study hospital, allow examination of the placenta after delivery as part of the study reference standard.
Visão geral do estudo
Status
Condições
Descrição detalhada
Participants with singleton pregnancies attending first-trimester combined screening between 11+0 and 13+6 weeks will be invited to participate. The research-specific placental cord-insertion assessment will be performed after completion of routine clinical care and will not replace or alter standard ultrasound assessment. The insertion will be initially classified as normal, VCI, or undetermined.
VCI or undetermined examinations will undergo repeat ultrasound assessment in the same setting or within 1 week by maternal-fetal-medicine team, transvaginal ultrasound may be considered to facilitate visualization. If an abnormal insertion is confirmed, subsequent care, including repeat assessment and transvaginal ultrasound for vasa previa where clinically indicated, will follow existing practice.
For participants who deliver at the study hospital, available placentas will undergo blinded structured postnatal gross examination and standardized photographic documentation. The final postnatal placental classification, reviewed by an assessor blinded to antenatal ultrasound classifications and neonatal outcome, will serve as the reference standard for the primary diagnostic-accuracy analysis.
Tipo de estudo
Inscrição (Estimado)
Contactos e Locais
Contato de estudo
- Nome: Linus Lee
- Número de telefone: 852-25957359
- E-mail: llt511@ha.org.hk
Locais de estudo
-
-
-
Hong Kong, Hong Kong
- Pamela Youde Nethersole Eastern Hospital
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
The study population comprises pregnant participants aged 18 years or older with singleton pregnancies who attend routine first-trimester combined screening at Pamela Youde Nethersole Eastern Hospital Hong Kong between 11+0 and 13+6 weeks of gestation. Participants must have capacity to provide written informed consent. Individuals with multiple pregnancies and those who decline or withdraw consent will not be included. All enrolled participants will undergo the same focused, research-specific transabdominal ultrasound assessment of the placental cord-insertion site after completion of their routine clinical screening examination.
Descrição
Inclusion Criteria:
- Pregnant participants aged 18 years or older with a singleton pregnancy
- Attendance for first-trimester combined screening at 11+0 to 13+6 weeks
- Capacity to provide written informed consent
Exclusion Criteria:
- Multiple pregnancy
- Declined or withdrawn consent
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Modelos de observação: COHORT
- Perspectivas de Tempo: PROSPECTIVE
Coortes e Intervenções
Grupo / Coorte |
|---|
|
Singleton pregnancies undergoing first-trimester placental cord-insertion assessment
Consenting pregnant participants aged 18 years or older with singleton pregnancies attending first-trimester combined screening at Pamela Youde Nethersole Eastern Hospital Hong Kong at 11+0 to 13+6 weeks gestation. Following routine screening, participants undergo a focused transabdominal placental cord-insertion assessment of up to 3 additional minutes, with review or repeat assessment according to the prespecified pathway where needed. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Sensitivity of First-Trimester Ultrasound for Detecting Velamentous Cord Insertion
Prazo: Up to 7 months after the baseline assessment, at postnatal placental examination.
|
Sensitivity of first-trimester ultrasound for detection of velamentous cord insertion |
Up to 7 months after the baseline assessment, at postnatal placental examination.
|
|
Specificity of First-Trimester Ultrasound for Detecting Velamentous Cord Insertion
Prazo: Up to 7 months after the baseline assessment, at postnatal placental examination.
|
Specificity of first-trimester ultrasound for detection of velamentous cord insertion |
Up to 7 months after the baseline assessment, at postnatal placental examination.
|
|
Percentage of Participants with a Definitive Classification Within the Initial 3-Minute Ultrasound Assessment
Prazo: Baseline
|
Proportion of participants classified as either normal placental cord insertion or velamentous cord insertion within the prespecified 3-minute focused ultrasound assessment. |
Baseline
|
|
Percentage of Participants with a Definitive Classification After Completion of the Assessment Pathway
Prazo: Up to 1 week after the baseline assessment
|
Proportion of participants with a final classification of either normal placental cord insertion or velamentous cord insertion after maternal-fetal-medicine review and/or repeat ultrasound assessment, where required. |
Up to 1 week after the baseline assessment
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Percentage of Participants with an Indeterminate Initial Placental Cord-Insertion Assessment
Prazo: Baseline
|
Proportion of participants with an indeterminate initial placental cord-insertion classification and documented reasons for indeterminate assessment, if any |
Baseline
|
|
Neonatal Birth Weight
Prazo: At delivery
|
Birth weight recorded at delivery, and local gestational age specific centiles where available |
At delivery
|
|
Gestational age at delivery
Prazo: At delivery
|
Gestational age in completed weeks at delivery |
At delivery
|
|
Mode of delivery
Prazo: At delivery
|
Mode of delivery recorded from maternity records |
At delivery
|
|
Neonatal Apgar Scores at 1 and 5 Minutes After Birth
Prazo: At delivery episode, 1 and 5 minutes after birth
|
Apgar scores assessed at 1 and 5 minutes after birth. Scores range from 0 to 10, with higher scores indicating better neonatal condition. |
At delivery episode, 1 and 5 minutes after birth
|
|
NICU admission
Prazo: At delivery episode
|
Admission to a neonatal intensive care unit |
At delivery episode
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Hypertensive disorders of pregnancy
Prazo: From baseline assessment to delivery, up to 7 months
|
Incidence of gestational hypertension, pre-eclampsia, or chronic hypertension with superimposed pre-eclampsia, summarized descriptively according to antenatal and postnatal placental cord-insertion status |
From baseline assessment to delivery, up to 7 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Linus Lee, Hospital Authority
Publicações e links úteis
Publicações Gerais
- Padula F, Lagana AS, Vitale SG, Mangiafico L, D'Emidio L, Cignini P, Giorlandino M, Gulino FA, Capriglione S, Giorlandino C. Ultrasonographic evaluation of placental cord insertion at different gestational ages in low-risk singleton pregnancies: a predictive algorithm. Facts Views Vis Obgyn. 2016 Mar 28;8(1):3-7.
- Siargkas A, Tsakiridis I, Pachi C, Mamopoulos A, Athanasiadis A, Dagklis T. Impact of velamentous cord insertion on perinatal outcomes: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2023 Feb;5(2):100812. doi: 10.1016/j.ajogmf.2022.100812. Epub 2022 Nov 12.
- Derisbourg S, Boulay A, Lamy C, Barlow P, Van Rysselberge M, Thomas D, Rozenberg S, Daelemans C. First trimester ultrasound prediction of velamentous cord insertions: a prospective study. J Matern Fetal Neonatal Med. 2021 Aug;34(16):2642-2648. doi: 10.1080/14767058.2019.1670797. Epub 2019 Sep 26.
- Sepulveda W, Rojas I, Robert JA, Schnapp C, Alcalde JL. Prenatal detection of velamentous insertion of the umbilical cord: a prospective color Doppler ultrasound study. Ultrasound Obstet Gynecol. 2003 Jun;21(6):564-9. doi: 10.1002/uog.132.
- Sepulveda W. Velamentous insertion of the umbilical cord: a first-trimester sonographic screening study. J Ultrasound Med. 2006 Aug;25(8):963-8; quiz 970. doi: 10.7863/jum.2006.25.8.963.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- CIRB-2026-562-1
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Individual participant data will not be shared outside the study team because the study involves potentially identifiable pregnancy, ultrasound, placental, and perinatal clinical data held under institutional data-governance and privacy requirements. De-identified aggregate data may be available in publications or on reasonable request, subject to applicable approval and requirements.
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .